Earlier this week, “Comirnaty,” Pfizer-BioNTech’s COVID-19
vaccine received full authorization by the Food and
Drug Administration (FDA).
The Pfizer-BioNTech two-dose regimen has been distributed under
an “emergency use authorization” for the past eight months.
Following an in-depth review of trial data and millions of doses
delivered, Comirnaty was approved, while the Moderna two-dose
regimen and the single-dose Johnson&Johnson/Janssen product
remain under emergency use authorization.
Doses of Comirnaty are authorized for those aged 16 and up. For
those between 12 and 15, all three vaccines are still only
approved for emergency use. Trials of all three vaccines in
children younger than 12 are also in progress.
Authorization of Comirnaty is expected to persuade some
vaccine-hesitant Californians to get vaccinated. As of August 23,
according to the CDC, 79.4 percent of eligible Californians
have received at least one dose of a vaccine.
How Exactly Do You Pronounce Comirnaty?
Courtesy of USA Today News (August 23, 2021), Click
here for a direct link to the article.
The Pfizer-BioNTech vaccine is pronounced “co-MER-na-tee”
according to Scott Piergrossi, president of creative for the
Brand Institute, which crafted the name.
It’s a little easier to say than BNT162b2, the research name of
the vaccine while it was first being studied, but not much.
Why Comirnaty? According to the companies, it “represents a
combination of the terms COVID-19, mRNA, community, and
immunity.”
